Literature DB >> 27407633

Newer Perspectives of Childhood Asthma.

Keya Lahiri1, Mrunalini Chavarkar2.   

Abstract

Keywords:  Asthma; Bronchial; Paediatrics; Steroids

Year:  2011        PMID： 27407633      PMCID： PMC4923057          DOI： 10.1016/S0377-1237(04)80046-7

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  24 in total

1.  Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis.

Authors:  E Adelroth; S Rak; T Haahtela; G Aasand; L Rosenhall; O Zetterstrom; A Byrne; K Champain; J Thirlwell; G D Cioppa; T Sandström
Journal:  J Allergy Clin Immunol       Date:  2000-08       Impact factor: 10.793

2.  Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.

Authors:  B Knorr; J Matz; J A Bernstein; H Nguyen; B C Seidenberg; T F Reiss; A Becker
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

3.  Anti-inflammatory effect of suplatast tosilate on mild asthma.

Authors:  Y Sano; T Miyamoto; S Makino
Journal:  Chest       Date:  1997-09       Impact factor: 9.410

4.  The significance of regional pulmonary function changes in bronchial asthma.

Authors:  A F Wilson; E L Surprenant; G N Beall; S C Siegel; D H Simmons; L R Bennett
Journal:  Am J Med       Date:  1970-04       Impact factor: 4.965

5.  Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma.

Authors:  J P Kemp; R J Dockhorn; G G Shapiro; H H Nguyen; T F Reiss; B C Seidenberg; B Knorr
Journal:  J Pediatr       Date:  1998-09       Impact factor: 4.406

6.  Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.

Authors:  J Tamaoki; M Kondo; N Sakai; K Aoshiba; E Tagaya; J Nakata; K Isono; A Nagai
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

7.  The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis.

Authors:  B M Schmidt; W Timmer; A C Georgens; M Hilt; C Mattinger; W Wurst; K Hörmann; M Wehling
Journal:  J Clin Pharmacol       Date:  1999-10       Impact factor: 3.126

8.  Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.

Authors:  A Hamilton; I Faiferman; P Stober; R M Watson; P M O'Byrne
Journal:  J Allergy Clin Immunol       Date:  1998-08       Impact factor: 10.793

9.  Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction.

Authors:  R Dahl; S A Johansson
Journal:  Eur J Respir Dis Suppl       Date:  1982

10.  A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma.

Authors:  C T Furukawa; G G Shapiro; C W Bierman; M J Kraemer; D J Ward; W E Pierson
Journal:  Pediatrics       Date:  1984-10       Impact factor: 7.124
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.